Major pathological response and durable locoregional control after neoadjuvant pembrolizumab-carboplatin-paclitaxel in head and neck cancer

  1. Cabezas-Camarero, S.
  2. Alonso-Ovies, A.
  3. Merino-Menéndez, S.
  4. Cabrera-Martín, M.N.
  5. Plaza-Hernández, J.C.
  6. Pérez-Segura, P.
Journal:
Oral Oncology

ISSN: 1879-0593,  1368-8375

Year of publication: 2021

Volume: 123

Type: Letter

DOI: 10.1016/J.ORALONCOLOGY.2021.105589 GOOGLE SCHOLAR
Data source: Scopus